Sam Hall is a principal at Apple Tree Partners, a New York-based venture capital firm. Sam has experience in life sciences across roles as a scientist, private equity investor, and investment banker. Prior to joining Apple Tree Partners in 2013, he was a researcher at the University of Cambridge in the UK, where his work focused on novel therapeutic strategies for autoimmune diseases. Previously, Dr. Hall was a member of the investment team at Symphony Capital, a private equity firm dedicated to investments in biopharmaceuticals. Prior to Symphony, he served as a member of the healthcare investment banking team at Citigroup, where he advised leading biotechnology, medical device and healthcare services businesses on numerous completed strategic, debt and equity financings. Dr. Hall earned his Ph.D. at the University of Cambridge.